For two decades, CardioRisk Laboratories has offered CIMT screening at established partner locations nationwide — guided by a team of clinicians and cardiovascular-prevention experts.
Todd directs all activities of the company with a focus on new technology, quality, and marketing, and brings over 20 years of senior and executive management experience. He holds an MBA from Brigham Young University, an MPH, and a PhD in cardiovascular epidemiology, and is the author of the best-selling Cardiovascular Wellness Management Success Plan.
Before joining CardioRisk, Ken held multiple senior and executive management positions at publicly traded and large private companies. At CardioRisk he leads sales and business-development efforts.
CardioRisk's clinical direction draws on recognized leaders in cardiovascular prevention.
A recognized leader in cardiovascular prevention, Dr. Doneen is the cofounder and a principal instructor of the BaleDoneen Method — a genetically guided, precision-medicine approach practiced by healthcare providers worldwide.
A physician focused on cardiovascular and metabolic risk prevention, Dr. Brewer founded PrevMed Health and advises CardioRisk on screening and prevention practice.
CardioRisk's clinical direction shares one belief: many cardiovascular events are foreseeable, and earlier insight gives patients more room to act.
